Status:
COMPLETED
Incisional Correction of Corneal Astigmatism During Phacoemulsification
Lead Sponsor:
Al-Rasheed University College
Collaborating Sponsors:
Baghdad Medical City
Conditions:
Astigmatism
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Today, cataract surgery is regarded as refractive surgery, mainly aiming emmetropia, and this makes eliminating corneal astigmatism is critical. Corneal astigmatism of more than 1 diopter has been rep...
Eligibility Criteria
Inclusion
- Clear cornea
- No history of previous ocular surgery
- Central corneal thickness (CCT) \<640
Exclusion
- Irregular corneal astigmatism or lenticular astigmatism
- Corneal opacities or pathology like Fuch's endothelial dystrophy
- Previous ocular surgeries like glaucoma surgery or PKP or pterygium excision
- Posterior segment diseases and pathology
- Complicated phacoemulsification
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04418986
Start Date
July 1 2019
End Date
September 30 2019
Last Update
June 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghazi al-Hariri Surgical Specialties Hospital
Baghdad, Bab-Almuadham, Iraq, 12221